Dacarbazine
Dacarbazine for Injection, USP is indicated in the treatment of metastatic malignant melanoma. In addition, dacarbazine is also indicated for Hodgkin's disease as a second-line therapy when used in combination with other effective agents.
United States
$265
per month
India
$55
per month
You save
−79%save $209/mo · 79% cheaper
34 US scripts/yr$7.1K potential annual savings$9K US spend/yr
Drag to rotate · 3D structureC6H10N6O
SMILES: CN(C)/N=N/C1=C(NC=N1)C(=O)N
Compare the price
US price$265per month
India price$55per month
You save$20979% less
Based on 30 units per month. US $8.82 vs India $1.84 per unit.
Total over 1 periodSave $209$265 → $55
The bigger picture
Dacarbazine is filled about 34 times a year under Medicare Part D. At the prices above, that works out to roughly:
Est. annual US spend
$9K
If sourced from India
$1.9K
Potential annual savings
$7.1K
−79%
Rough estimate. Based on Medicare Part D prescription volume (not the entire US market) scaled by the representative monthly price — actual totals depend on dose, duration and coverage.